Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 14:2018:6024698.
doi: 10.1155/2018/6024698. eCollection 2018.

Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis

Rachel K Scott  1   2 , Stacia Crochet  3 , Chun-Chih Huang  1   4
Affiliations

Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis

Rachel K Scott et al. Infect Dis Obstet Gynecol. .

Abstract

Objective: To determine the cost-effectiveness of universal maternal HIV screening at time of delivery to decrease mother-to-child transmission (MTCT), by comparing the cost and quality-adjusted life years (QALYs) of universal rapid HIV screening at time of delivery to two current standards of care for prenatal HIV screening in the United States.

Study design: We conducted a cost-effectiveness analysis to compare the cost and QALY of universal intrapartum rapid HIV screening with two current standards of care: (I) opt-out rapid HIV testing limited to patients without previous third-trimester screening and (II) opt-out rapid HIV testing limited to patients without any prenatal screening. We developed a decision-tree model and performed sensitivity analyses to estimate the impact of variances in QALY, estimated lifetime medical costs, HIV prevalence, and cumulative incidence.

Results: The incremental cost-effectiveness ratio for universal screening was $7,973.45/QALY. The results remained robust to sensitivity analysis, except for annual cumulative incidence. In areas with an annual cumulative incidence rate of <0.02% for reproductive-age women, the incremental cost-effectiveness ratio for the expanded program would exceed $89,926.94/QALY, approaching the commonly applied cost-effectiveness thresholds ($100,000/QALY).

Conclusions: Intrapartum universal rapid HIV screening to decrease MTCT appears cost-effective in populations with high HIV incidence in the United States.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Simplified depiction of decision-tree used for the analysis. (a) Three strategies, universal rapid HIV screening, standard of care I, and standard of care II, are compared in the analysis. (b) Scenarios based on prenatal HIV screening and the screening result. (For simplicity, the figure assumes 100% sensitivity and 100% specificity for the prenatal HIV screening.) (c) The care pattern for patients undergoing intrapartum rapid screening. (d) The care pattern for patients not undergoing intrapartum rapid screening. US: universal screening; SC1, standard of care I; SC2, standard of care II; RS, rapid screen; UC, usual care; MP, maternal prophylaxis; NP, neonatal prophylaxis; T1, first trimester; T3, third trimester.
Figure 2
Figure 2
One-way sensitivity analysis: impact of annual cumulative incidence on ICER (universal screening relative to standard of care in the DC area).
Figure 3
Figure 3
Two-way sensitivity analysis: impact of QALY saved per prevented case of MTCT and lifetime medical costs of PAH on ICER (universal screening relative to standard of care in the DC area).
See this image and copyright information in PMC

References

    1. Drake A. L., Wagner A., Richardson B., John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Medicine. 2014;11(2) doi: 10.1371/journal.pmed.1001608.e1001608 - DOI - PMC - PubMed
    1. Camacho-Gonzalez A. F., Kingbo M.-H., Boylan A., Eckard A. R., Chahroudi A., Chakraborty R. Missed opportunities for prevention of mother-to-child transmission in the United States. AIDS. 2015;29(12):1511–1515. doi: 10.1097/QAD.0000000000000710. - DOI - PMC - PubMed
    1. CDC. Achievements in public health: reduction in perinatal transmission of HIV infection---United States, 1985-2005. Morbidity and Mortality Weekly Report (MMWR) 2006:592–597. - PubMed
    1. ACOG. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Committee Opinion. 2015 - PubMed
    1. Branson B. M., Handsfield H. H., Lampe M. A., Janssen R. S., Taylor A. W., Lyss S. B. MMWR Recommendations and Reports. Vol. 55. Centers for Disease Control and Prevention (CDC); 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings; pp. 1–17. - PubMed

Publication types

LinkOut - more resources